Your browser doesn't support javascript.
loading
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).
Neurobiol Aging ; 4(4): 261-71, 1983.
Article de En | MEDLINE | ID: mdl-6200784
ABSTRACT
In postmortem investigations of patients with dementia of Alzheimer type (AD/SDAT) (n = 14) the brain weight was significantly reduced when compared to controls (n = 16). In four AD/SDAT-brain parts investigated the concentrations of 5-hydroxy-tryptamine and noradrenaline were significantly reduced while 3-methoxy-4-hydroxyphenylglycol was significantly increased. In the caudate nucleus of the AD/SDAT-brains the concentrations of dopamine and homovanillic acid were significantly reduced. The activity of monoamine oxidase B was increased suggesting a proliferation of extra neuronal tissue in the AD/SDAT-brains. The activity of choline acetyl transferase was reduced in the four brain parts investigated, showing a general reduction in the acetylcholine system in the AD/SDAT-brains. The ganglioside concentration was significantly reduced suggesting a reduced density of nerve endings in the demented brains. The AD/SDAT-group was according to rating scales severely demented. Patients with an early onset of the dementia disease were more severely intellectually reduced and had more pronounced biochemical disturbances than those with a late onset of the dementia.
Sujet(s)
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Récepteur muscarinique / Agents neuromédiateurs / Maladie d'Alzheimer / Gangliosides Limites: Aged / Female / Humans / Male Langue: En Journal: Neurobiol Aging Année: 1983 Type de document: Article
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Récepteur muscarinique / Agents neuromédiateurs / Maladie d'Alzheimer / Gangliosides Limites: Aged / Female / Humans / Male Langue: En Journal: Neurobiol Aging Année: 1983 Type de document: Article